MedPal AI (LSE:MPAL) Change In Receivables: £-1.14 Mil (TTM As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is MedPal AI Change In Receivables?

MedPal AI LSE:MPAL Change In Receivables is £-1.14 Mil as of Feb. 2026. The stock has 1 warning sign investors should review.

MedPal AI's change in receivables for the quarter that ended in Feb. 2026 was £-0.96 Mil. It means MedPal AI's Accounts Receivable increased by £0.96 Mil from Aug. 2025 to Feb. 2026 .

MedPal AI's change in receivables for the fiscal year that ended in Aug. 2025 was £-0.22 Mil. It means MedPal AI's Accounts Receivable increased by £0.22 Mil from Aug. 2024 to Aug. 2025 .

MedPal AI's Accounts Receivable for the quarter that ended in Feb. 2026 was £0.29 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. MedPal AI's Days Sales Outstanding for the six months ended in Feb. 2026 was 33.34.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. MedPal AI's liquidation value for the six months ended in Feb. 2026 was £-1.48 Mil.

MedPal AI  (LSE:MPAL) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

MedPal AI's Days Sales Outstanding for the quarter that ended in Feb. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.293/1.604*91
=33.34

2. In Ben Graham's calculation of liquidation value, MedPal AI's accounts receivable are only considered to be worth 75% of book value:

MedPal AI's liquidation value for the quarter that ended in Feb. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.004-1.807+0.75 * 0.293+0.5 * 0.215
=-1.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedPal AI Change In Receivables Related Terms

MedPal AI Change In Receivables Historical Data

* Premium members only.

The historical data trend for MedPal AI's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedPal AI Change In Receivables Chart

MedPal AI Annual Data
Trend Aug22 Aug23 Aug24 Aug25
Change In Receivables
-0.00 0.00 0.00 -0.22

MedPal AI Semi-Annual Data
Aug22 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
Change In Receivables Get a 7-Day Free Trial -0.00 0.00 -0.04 -0.19 -0.96

MedPal AI Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Feb. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-1.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of £-1.14 Mil mean?
MedPal AI (LSE:MPAL) has a Change In Receivables of £-1.14 Mil as of Feb. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for MedPal AI and its competitors.
Is MedPal AI's Change In Receivables too high?
MedPal AI's current Change In Receivables is £-1.14 Mil.
How does MedPal AI's Change In Receivables compare to VEEV and BTSG?
MedPal AI's Change In Receivables of £-1.14 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Healthcare Providers & Services company?
A good Change In Receivables depends on the Healthcare Providers & Services industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for MedPal AI and its competitors. MedPal AI's current Change In Receivables is £-1.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedPal AI stock overvalued right now?
MedPal AI (LSE:MPAL) has a current Change In Receivables of £-1.14 Mil. The current Change In Receivables is £-1.14 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For MedPal AI (LSE:MPAL), the current Change In Receivables is £-1.14 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedPal AI Business Description

Other Exchanges Z1N:Germany
Address 71 Queen Victoria Street, Floor 8, London, GBR, EC4V 4AY
MedPal AI PLC is a UK-based digital health and artificial intelligence company focused on the development and commercialisation of AI-enabled healthcare platforms.. Its platform aggregates data across devices and apps (including Apple Health, Fitbit, Garmin, and Google Fit) to deliver real-time, personalized health insights. The Company has two reportable segments, Software and Corporate.